Suchergebnisse - "Kuryk, Łukasz"

PubPharm (76)

1

Priming with oncolytic adenovirus followed by anti-PD-1 and paclitaxel treatment leads to improved anti-cancer efficacy in the 3D TNBC model

enthalten in: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V | 2024

von Kuryk, L. | Mathlouthi, S. | Wieczorek, M. | +7

2

Development of mesothelioma-specific oncolytic vaccine exploiting immunopeptidomic analysis of murine and human tumors

enthalten in: ResearchSquare.com | 2023

von Chiaro, J. | Antignani, G. | Feola, S. | +19

3

Development of mesothelioma-specific oncolytic immunotherapy enabled by immunopeptidomics of murine and human mesothelioma tumors

enthalten in: Nature communications | 2023

von Chiaro, J. | Antignani, G. | Feola, S. | +21

4

Combining adenovirus and checkpoint inhibitors for treating cancer

enthalten in: Europäisches Patentamt | 2023

von RANKI TUULI | PESONEN SARI ANNELI | JÄDERBERG MAGNUS | +3

5

Combining adenovirus and checkpoint inhibitors for treating cancer

enthalten in: Europäisches Patentamt | 2023

von RANKI TUULI | PESONEN SARI ANNELI | JÄDERBERG MAGNUS | +3

6

Mast Cells as a Target-A Comprehensive Review of Recent Therapeutic Approaches

enthalten in: Cells | 2023

von Baran, J. | Sobiepanek, A. | Mazurkiewicz-Pisarek, A. | +5

7

Oncolytic Adenoviruses Armed with Co-Stimulatory Molecules for Cancer Treatment

enthalten in: Cancers | 2023

von Gryciuk, A. | Rogalska, M. | Baran, J. | +2

8

Next generation oncolytic viruses expressing PADI1 and TIMP2 exhibit anti-tumor activity against melanoma in nude and humanized mouse models

enthalten in: Molecular therapy oncolytics | 2023

von Kuryk, L. | Møller, A.

9

MODIFIED ADENOVIRUSES FOR INFECTIOUS DISEASE VACCINE DEVELOPMENT

enthalten in: Europäisches Patentamt | 2023

von CERULLO VINCENZO | VÄHÄ-KOSKELA MARKUS | HIRVINEN MARI | +4

10

Novel combinatorial therapy of oncolytic adenovirus AdV5/3-D24-ICOSL-CD40L with anti PD-1 exhibits enhanced anti-cancer efficacy through promotion of intratumoral T-cell infiltration and modulation of tumour microenvironment in mesothelioma mouse model

enthalten in: Frontiers in oncology | 2023

von Garofalo, M. | Wieczorek, M. | Anders, I. | +13

1
2
3
4
5
6
7
8
Nächster »
[8]